F-group (family)
2006.1.3.3 Toprim,TOPRIM_C
Ligands and drugs
112
Member domains
40
with ligand contacts (≤ 4 Å)
35.7% of members
30
with DrugDomain annotations
26.8% of members
19
with a DrugBank compound
17.0% of members
Aggregated over all current member domains of this group. Drug annotations come from DrugDomain; buffers and crystallization additives are excluded from the tables below.
Chemical profile
Chemical profiles are computed for X-groups. 2006.1.3.3 belongs to X-group 2006 HAD domain-like, which binds 9.7 ligand superclasses per 20 proteins, broader than 91% of the 256 X-groups with enough proteins to compare. View its chemical profile →
DrugBank compounds
| DrugBank | PDB ligand | Name | Domains |
|---|---|---|---|
| DB00773 | EVP | Etoposide | 10 |
| DB00276 | ASW | Amsacrine | 3 |
| DB01204 | MIX | Mitoxantrone | 3 |
| DB08651 | TSP | 3'-THIO-THYMIDINE-5'-PHOSPHATE | 3 |
| DB00380 | — | Dexrazoxane | 2 |
| DB00694 | — | Daunorubicin | 2 |
| DB00997 | — | Doxorubicin | 2 |
| DB05022 | — | — | 2 |
| DB06362 | — | — | 2 |
| DB06421 | — | — | 2 |
| DB00218 | — | Moxifloxacin | 1 |
| DB00385 | — | — | 1 |
| DB00444 | — | Teniposide | 1 |
| DB00445 | — | — | 1 |
| DB00467 | — | — | 1 |
| DB00487 | — | — | 1 |
| DB00537 | — | Ciprofloxacin | 1 |
| DB00685 | — | Trovafloxacin | 1 |
| DB00978 | — | — | 1 |
| DB01059 | — | — | 1 |
Most frequently bound compounds
| PDB ligand | Name | Domains in contact |
|---|---|---|
| MGmetal | MAGNESIUM ION | 22 |
| EVP | (5S,5aR,8aR,9R)-9-(4-hydroxy-3,5-dimethoxyphenyl)-8-oxo-5,5a,6,8,8a,9-hexahydrofuro[3',4':6,7]naphtho[2,3-d][1,3]dioxol-5-yl 4,6-O-[(1R)-ethylidene]-beta-D-glucopyranoside | 16 |
| AKE | 1,4-bis({2-[(2-hydroxyethyl)amino]ethyl}amino)anthracene-9,10-dione | 2 |
| ASW | N-[4-(acridin-9-ylamino)-3-methoxyphenyl]methanesulfonamide | 2 |
| MIX | 1,4-DIHYDROXY-5,8-BIS({2-[(2-HYDROXYETHYL)AMINO]ETHYL}AMINO)-9,10-ANTHRACENEDIONE | 2 |
| MNmetal | MANGANESE (II) ION | 2 |
| N2N | dichloro{4,5-di(amino-kappaN)-N-[9-(4-hydroxy-3,5-dimethoxyphenyl)-8-oxo-5,5a,6,8,8a,9-hexahydro-2H-furo[3',4':6,7]naphtho[2,3-d][1,3]dioxol-5-yl]pentanamide}platinum | 2 |
| N2R | dichloro{4,5-di(amino-kappaN)-N-[9-(4-hydroxy-3,5-dimethoxyphenyl)-8-oxo-5,5a,6,8,8a,9-hexahydro-2H-furo[3',4':6,7]naphtho[2,3-d][1,3]dioxol-5-yl]pentanamide}platinum | 2 |
| N2S | chloro{4,5-di(amino-kappaN)-N-[9-(4-hydroxy-3,5-dimethoxyphenyl)-8-oxo-5,5a,6,8,8a,9-hexahydro-2H-furo[3',4':6,7]naphtho[2,3-d][1,3]dioxol-5-yl]pentanamide}platinum | 2 |
| N2W | chloro{4,5-di(amino-kappaN)-N-[9-(4-hydroxy-3,5-dimethoxyphenyl)-8-oxo-5,5a,6,8,8a,9-hexahydro-2H-furo[3',4':6,7]naphtho[2,3-d][1,3]dioxol-5-yl]pentanamide}platinum | 2 |
| TSP | 3'-THIO-THYMIDINE-5'-PHOSPHATE | 2 |
| YWX | 2-{3-[(Z)-iminomethyl]-1H-1,2,4-triazol-1-yl}-1-{(3M)-3-[2-(trifluoromethyl)phenyl]-6H-pyrrolo[3,4-b]pyridin-6-yl}ethan-1-one | 2 |
| ZNmetal | ZINC ION | 1 |